OTCMKTS:OXYS - OxySure Therapeutics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$0.0333Today's Range$0.0251 - $0.033552-Week Range$0.0010 - $0.1490Volume53,810 shsAverage Volume135,131 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email OxySure Therapeutics, Inc. designs, manufactures, and distributes specialty respiratory and emergency medical solutions in the United States and internationally. It offers OxySure Model 615, a portable emergency oxygen system. The company also provides complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. Its products enhance the access to emergency oxygen that affects the survival, recovery, and safety of individuals in various areas of need. The company primarily sells its products to institutional customers through distributors, sub-distributors, and sales agents. The company was formerly known as OxySure Systems, Inc. and changed its name to OxySure Therapeutics, Inc. in November 2015. OxySure Therapeutics, Inc. was founded in 2004 and is headquartered in Frisco, Texas. On December 5, 2016, Oxysure Therapeutics, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Eastern District of Texas. Receive OXYS News and Ratings via Email Sign-up to receive the latest news and ratings for OXYS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:OXYS Previous Symbol CUSIPN/A Webwww.oxysure.com Phone972-294-6450 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable OxySure Therapeutics (OTCMKTS:OXYS) Frequently Asked Questions What is OxySure Therapeutics' stock symbol? OxySure Therapeutics trades on the OTCMKTS under the ticker symbol "OXYS." Has OxySure Therapeutics been receiving favorable news coverage? Headlines about OXYS stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. OxySure Therapeutics earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future. Who are some of OxySure Therapeutics' key competitors? Some companies that are related to OxySure Therapeutics include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Haemonetics (HAE), Insulet (PODD), ICU Medical (ICUI) and Penumbra (PEN). Who are OxySure Therapeutics' key executives? OxySure Therapeutics' management team includes the folowing people: Mr. Julian T. Ross M.B.A., Founder, Chairman, CEO, Pres, CFO, Principal Accounting Officer and Sec. (Age 51)Ms. Lisa Griffin, Director of Safety EducationMs. Kathryn Jayne, Director of Regulatory Affairs & Quality Assurance How do I buy shares of OxySure Therapeutics? Shares of OXYS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is OxySure Therapeutics' official website? The official website for OxySure Therapeutics is http://www.oxysure.com. How can I contact OxySure Therapeutics? OxySure Therapeutics' mailing address is 10880 JOHN W. ELLIOTT ROAD SUITE 600, Frisco TX, 75033. The company can be reached via phone at 972-294-6450 or via email at [email protected] MarketBeat Community Rating for OxySure Therapeutics (OTCMKTS OXYS)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 47 (Vote Outperform)Underperform Votes: 58 (Vote Underperform)Total Votes: 105MarketBeat's community ratings are surveys of what our community members think about OxySure Therapeutics and other stocks. Vote "Outperform" if you believe OXYS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXYS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/12/2018 by MarketBeat.com StaffFeatured Article: What is dollar cost averaging (DCA)?